Unlocking The Potential of NBPF4 as A Drug Target (G148545)

Target Name: NBPF4

NCBI ID: G148545

NBPF4

Other Name(s): FLJ32833 | Neuroblastoma breakpoint family member 4 | NBPF4_HUMAN | NBPF member 4 | Neuroblastoma breakpoint family, member 4

Unlocking The Potential of NBPF4 as A Drug Target

NBPF4 (FLJ32833) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and fibrosis. As a drug target, NBPF4 may be a promising target for the development of new treatments for a variety of diseases.

One of the key functions of NBPF4 is its role in the regulation of inflammation. In response to injury or infection, the body mounts an immune response to protect the body from infection and disease. This response involves the recruitment of immune cells to the site of injury or infection, where they help to clear the damage and prevent the spread of infection.

NBPF4 is involved in this process by regulating the movement of immune cells to the site of inflammation. It does this by interacting with a protein called PDGF-BB, which is also known as platelet-derived growth factor (PDGF). PDGF-BB is a potent stimulator of cell growth and division, and it is involved in the development and maintenance of tissues throughout the body.

In addition to its role in inflammation, NBPF4 is also involved in the regulation of fibrosis. Fibrosis is the thickening and scarring of connective tissue, which can lead to a variety of diseases, including heart failure, diabetes, and cancer.

NBPF4 is involved in the regulation of fibrosis by interacting with a protein called TGF-β1. TGF-β1 is aTransforming growth factor that is involved in the regulation of cell growth, differentiation, and inflammation. It is a potent stimulator of fibrosis, and it is involved in the development of scar tissue in wound healing and other processes.

Despite its involvement in the regulation of inflammation and fibrosis, NBPF4 is not yet a well-studied drug target. There are currently no known drugs that are specifically designed to target NBPF4, and there is a need for further research to determine its potential as a drug target.

In conclusion, NBPF4 is a protein that is involved in the regulation of inflammation and fibrosis. Its function is not yet well understood, but it is potential as a drug target for the development of new treatments for a variety of diseases. Further research is needed to determine its potential and to develop new treatments that specifically target NBPF4.

Protein Name: NBPF Member 4

The "NBPF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NBPF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets